Page 69 - Read Online
P. 69

Page 12 of 13              Tang et al. Mini-invasive Surg 2024;8:24  https://dx.doi.org/10.20517/2574-1225.2024.04

               33.      Levin EG, Tzelnick S, Yaacobi D, et al. Long-term complications associated with the management of sinonasal malignancies: a single
                   center experience. Acta Otorhinolaryngol Ital 2023;43:203-11.  DOI  PubMed  PMC
               34.      Shah RR, Maina IW, Patel NN, et al. Incidence, risk factors, and outcomes of endoscopic sinus surgery after endoscopic skull-base
                   surgery. Int Forum Allergy Rhinol 2020;10:521-5.  DOI  PubMed
               35.      Arnold A, Ziglinas P, Ochs K, et al. Therapy options and long-term results of sinonasal malignancies. Oral Oncol 2012;48:1031-7.
                   DOI
               36.      Torabi SJ, Spock T, Cardoso B, et al. Margins in sinonasal squamous cell carcinoma: predictors, outcomes, and the endoscopic
                   approach. Laryngoscope 2020;130:E388-96.  DOI
               37.      Nakamaru Y, Suzuki M, Kano S, et al. The role of endoscopic resection for selected patients with sinonasal squamous cell carcinoma.
                   Auris Nasus Larynx 2021;48:131-7.  DOI
               38.      Kong KA, Thorp BD, Sheth SH. The role of induction therapy for sinonasal cancers. Curr Treat Options Oncol 2023;24:162-9.  DOI
                   PubMed
               39.      Miller KC, Marinelli JP, Janus JR, et al. Induction therapy prior to surgical resection for patients presenting with locally advanced
                   esthesioneuroblastoma. J Neurol Surg B Skull Base 2021;82:e131-7.  DOI  PubMed  PMC
               40.      Su SY, Bell D, Ferrarotto R, et al. Outcomes for olfactory neuroblastoma treated with induction chemotherapy. Head Neck
                   2017;39:1671-9.  DOI
               41.      Tang A, Calcaterra M, Harris M, et al. The role of induction chemotherapy for orbital invasion in sinonasal malignancies: a systematic
                   review. Int Forum Allergy Rhinol 2024;14:1226-39.  DOI
               42.      Bossi P, Saba NF, Vermorken JB, et al. The role of systemic therapy in the management of sinonasal cancer: a critical review. Cancer
                   Treat Rev 2015;41:836-43.  DOI
               43.      Berger MH, Lehrich BM, Yasaka TM, Fong BM, Hsu FPK, Kuan EC. Characteristics and overall survival in pediatric versus adult
                   esthesioneuroblastoma: a population-based study. Int J Pediatr Otorhinolaryngol 2021;144:110696.  DOI  PubMed
               44.      Devaiah  AK,  Andreoli  MT.  Treatment  of  esthesioneuroblastoma:  a  16-year  meta-analysis  of  361  patients.  Laryngoscope
                   2009;119:1412-6.  DOI  PubMed
               45.      Mehta GU, Hanna EY, DeMonte F, Raza SM. Endoscopic endonasal resection of sinonasal/anterior skull base malignancy (Kadish C
                   esthesioneuroblastoma). Acta Neurochir 2018;160:361-6.  DOI  PubMed
               46.      Harvey RJ, Nalavenkata S, Sacks R, et al. Survival outcomes for stage-matched endoscopic and open resection of olfactory
                   neuroblastoma. Head Neck 2017;39:2425-32.  DOI  PubMed
               47.      Meccariello G, Deganello A, Choussy O, et al. Endoscopic nasal versus open approach for the management of sinonasal
                   adenocarcinoma: a pooled-analysis of 1826 patients. Head Neck 2016;38:E2267-74.  DOI  PubMed
               48.      Villaret AB, Yakirevitch A, Bizzoni A, et al. Endoscopic transnasal craniectomy in the management of selected sinonasal
                   malignancies. Am J Rhinol Allergy 2010;24:60-5.  DOI
               49.      Vergez S, Martin-Dupont N, Lepage B, De Bonnecaze G, Decotte A, Serrano E. Endoscopic vs transfacial resection of sinonasal
                   adenocarcinomas. Otolaryngol Head Neck Surg 2012;146:848-53.  DOI  PubMed
               50.      Turri-Zanoni M, Battaglia P, Lambertoni A, et al. Treatment strategies for primary early-stage sinonasal adenocarcinoma: a
                   retrospective bi-institutional case-control study. J Surg Oncol 2015;112:561-7.  DOI  PubMed
               51.      Lund VJ, Stammberger H, Nicolai P, et al. European position paper on endoscopic management of tumours of the nose, paranasal
                   sinuses and skull base. Rhinol Suppl 2010;22:1-143.  PubMed
               52.      Homma A, Nakamaru Y, Lund VJ, et al. Endonasal endoscopic surgery for sinonasal squamous cell carcinoma from an oncological
                   perspective. Auris Nasus Larynx 2021;48:41-9.  DOI
               53.      Abdelmeguid AS, Teeramatwanich W, Roberts DB, et al. Neoadjuvant chemotherapy for locoregionally advanced squamous cell
                   carcinoma of the paranasal sinuses. Cancer 2021;127:1788-95.  DOI
               54.      Tsetsos N, Poutoglidis A, Terzakis D, Epitropou I, Oostra A, Georgalas C. Primary intracranial adenoid cystic carcinoma: report of
                   three cases. J Neurol Surg B Skull Base 2023;84:329-35.  DOI  PubMed  PMC
               55.      Volpi L, Bignami M, Lepera D, et al. Endoscopic endonasal resection of adenoid cystic carcinoma of the sinonasal tract and skull base.
                   Laryngoscope 2019;129:1071-7.  DOI
               56.      Kashiwazaki R, Turner MT, Geltzeiler M, et al. The endoscopic endonasal approach for sinonasal and nasopharyngeal adenoid cystic
                   carcinoma. Laryngoscope 2020;130:1414-21.  DOI  PubMed  PMC
               57.      Lupinetti AD, Roberts DB, Williams MD, et al. Sinonasal adenoid cystic carcinoma: the M. D. Anderson Cancer Center experience.
                   Cancer 2007;110:2726-31.  DOI  PubMed
               58.      Gadkaree SK, Parikh AS, Barbarite E, et al. Adenoid cystic carcinoma of the nasopharynx with skull base involvement: retrospective
                   national cohort analysis of treatment paradigms, outcomes, and provider density. J Neurol Surg B Skull Base 2022;83:99-104.  DOI
                   PubMed  PMC
               59.      Amit M, Abdelmeguid AS, Watcherporn T, et al. Induction chemotherapy response as a guide for treatment optimization in sinonasal
                   undifferentiated carcinoma. J Clin Oncol 2019;37:504-12.  DOI  PubMed  PMC
               60.      Takahashi Y, Gleber-Netto FO, Bell D, et al. Identification of markers predictive for response to induction chemotherapy in patients
                   with sinonasal undifferentiated carcinoma. Oral Oncol 2019;97:56-61.  DOI  PubMed
               61.      Abdelmeguid A, Bell D, Hanna E. Neuroendocrine carcinoma and sinonasal undifferentiated carcinoma. Adv Otorhinolaryngol
                   2020;84:168-84.  DOI  PubMed
   64   65   66   67   68   69   70   71   72   73   74